Dabigatran, A Direct Thrombin Inhibitor, In Atrial Fibrillation: Is It Already Time For A Change In Oral Anticoagulation Therapy?

Lignende værker

• Efficacy And Safety of Dabigatran Etexilate Utilization With Concomitant Dual Antiplatelet Therapy In Atrial Fibrillation
  af: Centurión, Osmar Antonio
  Udgivet: (2014)
• Rate Control Strategy Elevated To Primary Treatment For Atrial Fibrillation: Has The Last Word Already Been Spoken?
  af: Centurión, Osmar Antonio, et al.
  Udgivet: (2014)
• Exposure–response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation
  af: Lip, Gregory Y. H., et al.
  Udgivet: (2015)
• Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage
  af: Lauer, Arne, et al.
  Udgivet: (2011)
• Direct thrombin inhibitors and factor Xa inhibitors for atrial fibrillation
  af: Mahtani, Kamal R, et al.
  Udgivet: (2017)